Research graph
References from Medicaid’s GLP-1 Coverage Gap: A Familiar and Correctable Policy Failure. Local targets link to admitted publications; unresolved targets remain external evidence.
Once-weekly semaglutide in adults with overweight or obesity
10.1056/nejmoa2032183 · 2021 · External reference
Semaglutide and cardiovascular outcomes in obesity without diabetes
10.1056/nejmoa2307563 · 2023 · External reference
Medicaid coverage for obesity medications: utilization and net-of-rebate spending
2026 · External reference
U.S. eligibility and preventable cardiovascular, diabetes, and kidney outcomes from semaglutide in the SELECT trial
10.1016/j.jacadv.2025.101773 · 2025 · External reference
Weight regain after cessation of medication for weight management: systematic review and meta-analysis
10.1136/bmj-2025-085304 · 2026 · External reference
GLP-1-induced weight loss and the female obesity penalty
2026 · External reference
Racial and ethnic disparities in opioid access and urine drug screening among older patients with poor-prognosis cancer near the end of life
10.1200/jco.22.01413 · 2023 · External reference
